Fig. 5From: Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancerKaplan-Meier survival analysis. The rectal cancer group overall survival curve. The rectal cancer group-specific 5-year overall survival (OS) rates were 55.2 % in group 1 and 43.1 % in group 2 (P = 0.11). These differences weren't statistically significantBack to article page